Recon: Lilly warns of impurities in compounded versions of its weight-loss drugs; Abivax denies rumors of takeover by AstraZeneca

• It’s the 50th anniversary of the US biotech industry. What will the next 50 years look like? (STAT)
• The FDA is targeting telehealth marketing of GLP-1 drugs. Who’s prescribing them? (STAT)
• RFK Jr.’s advisers had a plan to target covid shots. Then it fell apart. (The Washington Post)
• How GLP-1 weight loss compounders reshaped the drug industry (Endpoints)
• FDA merges adverse event trackers into one database, including vaccine side effects (Endpoints)
• FDA Signals Potential Updates to SUPAC Guidances—Comments Due June 1, 2026 (FDA Law Blog)
• Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research (Reuters)
• One-third of Americans cut back on other expenses to cover healthcare in 2025, survey shows (Reuters)

• Eli Lilly to invest $3 billion in China, seeks approval for weight loss pill (Reuters)
• EU Notified Bodies Warn MDR/IVDR Amendments Will Deliver Lower Levels Of Patient Safety (MedTech Insight)
• French Health Startup Alan Valued Above €5 Billion After Raise (Bloomberg)
• Haleon Bets on Asia (Bloomberg)

• Lilly warns of impurity risk in certain compounded forms of Mounjaro and Zepbound (Endpoints) (Reuters)
• Is Aldeyra Therapeutics waving red flags with consequences? (STAT)
• After touching the $1T club, Eli Lilly CEO David Ricks is making the moves to stay there (Endpoints)
• Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sank (Endpoints)
• Evotec plans up to 800 job cuts, four site closures in next phase of reorganization (Endpoints)
• RA Capital, Forbion appear to back Harbour's CTLA-4 partner Solstice (Endpoints)
• Abivax spokesperson denies takeover rumors reported by French media (Reuters)

• Stryker investigating cyberattack that caused widespread outage (MedTech Dive)
• Advita Ortho receives warning letter related to shoulder system (MedTech Dive)
• Insulet posts clinical data on fully closed-loop insulin delivery system (MedTech Dive)
• Vitestro raises $70M to ready blood collection robot for US launch (MedTech Dive)
• FDA Weighs Second Citizen Petition On Bamboo Health’s NarxCare (MedTech Insight)
• FDA Announces May Rollout For MAUDE Replacement (MedTech Insight)
• Agilent Pays $950M for Biocare Medical To Expand Pathology Reach (MedTech Insight)

• US sued by food stamp recipients over restrictions on sugary drinks, candy (Reuters)
• Bayer takes its battle on pesticide liability to Kansas (Reuters)

• US Medicare Proposes Buy American Rx Incentives, But What Is A ‘Domestic’ Medicine? (Pink Sheet)
• This billionaire wants to make science better, especially for AI (STAT)
• AI agents are rapidly spreading in health care, but validation is lacking (STAT)
• Momentum builds for a federal office of men’s health focused on disease prevention (STAT)
• I’m an NIH whistleblower. The scientific community cannot afford to avoid politics (STAT)
• A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback (STAT)
• 'Closed-loop' AI clinical care is coming soon, startups predict (Endpoints)
• CVS' Aetna pays $117.7 million to settle US claims it defrauded Medicare (Reuters)